Trial intelligence / Profile preview

Comparison of the anesthetic efficacy of articaine 4% in two supplemental anesthetic injections

IRCT2015072023253N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of articaine in irreversible pulpitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Primary anesthetic efficacy. Started Oct 2016; status: completed.

02

Drugs

articaine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on IRCT2015072023253N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015072023253N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call